Target intelligence / Profile preview

Lipopolysaccharide (LPS) lipid A phosphate groups (LPS lipid A phosphate)

Target
LPS lipid A phosphate
Molecular classification
Bacterial cell wall component, Glycolipid, Saccharolipid, Endotoxin
01

Overview

Lipid A phosphate head groups are essential components of the lipopolysaccharide (LPS) molecule, which constitutes the outer leaflet of the outer membrane in Gram-negative bacteria [6, 16]. These negatively charged phosphate groups are critical for maintaining the structural integrity of the bacterial cell envelope by coordinating divalent cations like magnesium and calcium [9, 20]. This arrangement creates a robust permeability barrier against hydrophobic antibiotics and detergents [5, 19]. In clinical medicine, these phosphate groups serve as the primary binding site for polymyxin antibiotics, such as colistin and polymyxin B [1, 8]. The electrostatic interaction between the cationic drugs and the anionic phosphates leads to the displacement of stabilizing cations, resulting in membrane destabilization and bacterial cell death [2, 12]. Furthermore, Lipid A is the 'endotoxin' portion of LPS, responsible for triggering potent inflammatory responses and septic shock through the activation of the human TLR4/MD-2 receptor complex [10, 15].

Other names
Lipid A phosphateEndotoxin phosphate groups1,4'-bisphosphorylated glucosamine disaccharideLPS phosphate head groups
02

Mechanism of action

Polymyxin antibiotics, such as colistin and polymyxin B, target the negatively charged phosphate groups of lipid A through electrostatic interactions [1, 2, 5]. This binding displaces divalent cations (calcium and magnesium) that normally stabilize the lipopolysaccharide (LPS) layer in the outer membrane [3, 6, 8]. The resulting destabilization increases membrane permeability, allowing the drug to penetrate and disrupt the inner cytoplasmic membrane, ultimately leading to the leakage of cellular contents and bacterial cell death [2, 3, 12].

03

Biological functions

Structural integrityPermeability barrierImmune responseEndotoxin activityCellular anchoring
04

Disease associations

InfectionSepsisSeptic shockInflammation
05

Safety considerations

NephrotoxicityNeurotoxicityNeuromuscular blockadeNarrow therapeutic index
06

Interacting drugs

Polymyxin B

5 more in the full profile.

07

Biomarkers

Lipopolysaccharide (LPS) levelsProcalcitoninC-reactive protein (CRP)Interleukin-6 (IL-6)

Beyond the preview

Go deeper on Lipopolysaccharide (LPS) lipid A phosphate groups (LPS lipid A phosphate).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide (LPS) lipid A phosphate groups (LPS lipid A phosphate).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call